Upgrade to SI Premium - Free Trial

Amgen (AMGN), Peers on Watch Ahead of Repetha Data at ACC.17 (REGN) (ESPR) (MDCO)

March 17, 2017 6:59 AM
Amgen (NASDAQ: AMGN) and its peers were in focus ahead of data on its PCSK9 inhibitor, Repatha, which is set ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Trader Talk

Next Articles